Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.
about
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.Bilateral atypical femoral fractures in a patient with multiple myeloma treated with intravenous bisphosphonate therapy.Bisphosphonates and atypical fractures of femur.Femoral stress fractures associated with long-term bisphosphonate treatment.BMP6-Engineered MSCs Induce Vertebral Bone Repair in a Pig Model: A Pilot Study.Case of femoral diaphyseal stress fracture after long-term risedronate administration diagnosed by iliac bone biopsyAtypical femoral fracturesAsperosaponin VI promotes bone marrow stromal cell osteogenic differentiation through the PI3K/AKT signaling pathway in an osteoporosis model.Atypical Complete Femoral Fractures Associated with Bisphosphonate Use or Not Associated with Bisphosphonate Use: Is There a Difference?Alendronate-Related Femoral Fracture in a premenopausal glucocorticoid treated patient.The impact of subtrochanteric fracture criteria on hip fracture classification.Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry.Stem cell therapy for osteoporosis.Review: epidemiology and pathophysiology of atypical femur fractures.Atypical femur fractures: a review.Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.Stress fractures: pathophysiology, clinical presentation, imaging features, and treatment options.Atypical femoral shaft fractures secondary to long-term bisphosphonate therapy.Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.Effects of low and high dose intraarticular tiludronate on synovial fluid and clinical variables in healthy horses-a preliminary investigation.Incidence of atypical nontraumatic diaphyseal fractures of the femur.Acetabular Insufficiency Fracture Following Prolonged Alendronate Use and the Failure of Total Hip Arthroplasty in "Frozen" Bone: Two Cases Report.Atraumatic femoral neck fracture during bisphosphonate treatment: case report and review of the literature.Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates.Les bisphosphonates dans le traitement de l’ostéoporose: Bienfaits attendus, torts potentiels et congés thérapeutiques.
P2860
Q33715141-30692325-4AF2-40A8-9769-41875BD0B33FQ33984172-44BEE17B-DBB3-4AC7-8080-4285CC38548CQ34032539-9F1BD26C-1B90-49C3-BCF5-7A60EAC978E1Q34986933-A2B18E14-74FD-4DF2-8052-99ED3DC6CCA5Q35723090-0CDA53D2-B810-46CF-ADFA-600CD756C143Q36387608-0A0ABFF9-F9E6-4306-A5B5-F70D2EEDBC31Q36822665-21C10662-C31C-46FF-B3AF-31E8FA145D7DQ37008039-F182B0BB-A83B-418F-B242-EBA50B6FD0D3Q37348766-ED60724F-8427-4F53-9ABE-C924030884DEQ37470866-702AFEF0-5678-427C-9EBF-D7F753E4BFDBQ37488949-8B24E1C3-AA8D-4CBB-8CBC-7B37F5A0C51CQ37874473-CF32ACB6-8423-46C6-876A-9238E482FB39Q38012357-A9403090-BE59-419C-AD67-94E22E2FCB3BQ38177180-AB1EFFE9-22FB-44B8-A0DB-3DC4E6C70EECQ38187901-FF4CB221-1071-476F-9D8E-8DA78473E222Q38257133-EAB646BA-9D10-4C99-81DB-353AEA0FE0C4Q38407862-ED8D872B-4033-433A-B5B3-1A5E0C988D6CQ38784529-A43AFC06-63D7-44E9-8E73-5DC0A45E861BQ38959195-D163C17D-7C16-4093-B3E5-236F9F7D4D7BQ39335004-11C3B551-2B7E-4C8C-9A06-15211C88BDF8Q40313121-E4948F2F-33BA-468A-AF5E-32526AFF54C6Q42867982-2541AC34-FC83-428D-9E37-0C489CB5D348Q44364497-C614CB69-78E9-4E7E-95C9-784AA4AE34F7Q47137237-FA1BA09C-A82B-4667-B25B-43B09EACBAECQ48110369-300FB25A-4CB3-4140-B9A9-45CC48C47371Q50960182-65926A7B-E33D-4AC3-A616-00B18D1BB8F8Q55452474-8448F4F1-0DE7-4DA1-B7CD-1B06BFF699E3
P2860
Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atypical subtrochanteric and f ...... ociation with bisphosphonates.
@en
Atypical subtrochanteric and f ...... ociation with bisphosphonates.
@nl
type
label
Atypical subtrochanteric and f ...... ociation with bisphosphonates.
@en
Atypical subtrochanteric and f ...... ociation with bisphosphonates.
@nl
prefLabel
Atypical subtrochanteric and f ...... ociation with bisphosphonates.
@en
Atypical subtrochanteric and f ...... ociation with bisphosphonates.
@nl
P1476
Atypical subtrochanteric and f ...... ociation with bisphosphonates.
@en
P2093
Felicia Cosman
Jeri W Nieves
P2888
P356
10.1007/S11914-010-0007-2
P577
2010-03-01T00:00:00Z